Dimitrios Farmakis earned a doctorate in hemoglobinopathy-associated heart disease from the National and Kapodistrian University of Athens (2003). He specialized in cardiology at Athens University Hospital (“Attikon”) and received his board certification in 2008. He received further training (in cardio-oncology at Bern University Hospital “Inselspital”; in Heart Failure at the University of Zurich; and in clinical trials at Harvard Medical School). He was in charge of the Cardiac Clinic for Hemoglobinopathies at Athens University Hospital (”Laiko”) in the period from 2012 to 2018, and has been in charge of the Cardio-Oncology Clinic at Athens University Hospital (“Attikon”) since 2015. In 2017, he was elected an Assistant Professor of Pathophysiology at the European University of Cyprus, and, one year later, became an Associate Professor of Physiology at the University of Cyprus. His research has focused on heart failure, hemoglobinopathies, cardiovascular pharmacology, and cardio-oncology. He is the immediate past president of the Working Group for Cardiomyopathies and Basic Research of the Hellenic Society of Cardiology, and he has received awards from Greek and international organizations and scientific bodies, such as the National and Kapodistrian University of Athens (first award of excellence for the doctoral thesis), the University of Patras (distinguished young cardiologist award), and Harvard Medical School (distinction for the capstone project proposal).